Clinical Trials Browser

Glioma × Panitumumab × CNS × Clear all

NCT03510208 2026-02-09

Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

Phase 1/2 Recruiting

Brain Neoplasms, Glioma

NCT01017653 2013-09-04

Panitumumab and Irinotecan for Malignant Gliomas

Phase 2 Terminated

16 enrolled 9 charts

Glioblastoma, Glioma, Gliosarcoma